Cidara Therapeutics Inc (NASDAQ:CDTX) Consolidated Diluted EPS At -3.2453

0

For the year ended 2015-12-31 Cidara Therapeutics Inc (NASDAQ:CDTX) basic consolidated EPS came $-3.2453. Furthermore, for the quarter closed 2015-12-31, it was $-3.2453.

Consolidated diluted EPS

Cidara Therapeutics Inc (NASDAQ:CDTX) consolidated diluted EPS was -3.2453 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it stood at $-3.2453.

EPS contribution from parent

Cidara Therapeutics Inc (NASDAQ:CDTX) basic EPS was $-3.2453 for the year ended 2015-12-31 from its parent entity. It was $-3.2453 for the quarter closed 2015-12-31.

EPS from continuing operations

Cidara Therapeutics Inc (NASDAQ:CDTX) EPS from continuing activities was $-3.2453 for the fiscal ended 2015-12-31. For the quarter ended 2015-12-31, this figure was $-3.2453.

Basic net EPS

Cidara Therapeutics Inc (NASDAQ:CDTX) basic net EPS was $-3.25 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it came at $-3.25.

Diluted EPS from parent

Cidara Therapeutics Inc (NASDAQ:CDTX) diluted EPS from parent entity came at $-3.2453 for the year ended 2015-12-31. For the quarter ended 2015-12-31 it was $-3.2453.

Net diluted EPS

Cidara Therapeutics Inc (NASDAQ:CDTX) net diluted EPS was $-3.25 for the fiscal closed 2015-12-31. For the quarter ended 2015-12-31, net diluted EPS was $-3.25.

Cidara Therapeutics Inc (NASDAQ:CDTX) net basic EPS was $-3.25 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it was $-3.25.

Basic diluted EPS

Cidara Therapeutics Inc (NASDAQ:CDTX) basic diluted EPS was $-0.7089 for the quarter ended 2015-12-31. For the year ended 2015-12-31, basic diluted EPS was $-0.7089.

For the year ended 2015-12-31, basic shares outstanding were 9.92 while for the quarter ended 2015-12-31 is 9.92.

For the fiscal ended 2015-12-31, the diluted outstanding shares were 9.92 and for the quarter ended 2015-12-31 it was 9.92. Earnings per share and diluted EPS are profitability metrics used in fundamental analysis of firms. EPS just takes into account a firm’s common shares, while diluted EPS considers all convertible securities. Per-share earnings measure the quantum of a company’s earnings on a per share basis. Basic EPS does not consider any dilutive impact that convertible securities leave on EPS. On contrary, diluted EPS is a tool used in fundamental study to gauge a firm’s quality of EPS, assuming there is conversion of all convertible securities.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 19 times, 1 visits today)